Short Communication:Enhancement of HIV Infection by Cellulose Sulfate
- 1 July 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 24 (7), 925-929
- https://doi.org/10.1089/aid.2008.0043
Abstract
Cellulose sulfate, a polyanionic compound derived from cotton, has been proposed as a topical microbicide to reduce the sexual transmission of HIV. However, a phase III clinical trial of a vaginal gel formulation of cellulose sulfate (Ushercell) had to be prematurely closed after early data indicated microbicide users had a higher rate of HIV infection than women using a placebo. The unexpected results of the cellulose sulfate trail prompted us to reexamine and attempt to replicate the available preclinical data for this compound and other polyanions. We show here that cellulose sulfate has a biphasic effect on HIV infection in vitro: at high concentrations it inhibits infection but at low concentrations it significantly and reproducibly increases HIV infection. This stimulatory effect is evident for the R5-tropic strains of virus responsible for sexual transmission, reflects the rate of infection rather than viral growth, and occurs at clinically relevant concentrations of the compound. An examination of published studies shows that the biphasic effect of cellulose sulfate was evident in previous research by independent laboratories and is also found for other polyanions such as dextrin sulfate and PRO2000. These data help in understanding the failure of the Ushercell clinical trial and indicate that cellulose sulfate is not safe for mucosal application in humans.Keywords
This publication has 28 references indexed in Scilit:
- Vaginal microbicides: moving ahead after an unexpected setbackAIDS, 2007
- Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 daysContraception, 2007
- Microbicides: A new frontier in HIV preventionBiologicals, 2006
- Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety studyContraception, 2006
- Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected womenAIDS, 2006
- Candidate Sulfonated and Sulfated Topical Microbicides: Comparison of Anti-Human Immunodeficiency Virus Activities and Mechanisms of ActionAntimicrobial Agents and Chemotherapy, 2005
- A Potent Anti-HIV Immunotoxin Blocks Spreading Infection by Primary HIV Type 1 Isolates in Multiple Cell TypesAIDS Research and Human Retroviruses, 2004
- Envelope-Dependent, Cyclophilin-Independent Effects of Glycosaminoglycans on Human Immunodeficiency Virus Type 1 Attachment and InfectionJournal of Virology, 2002
- Antibody-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Infectivity Is Determined by the Structure of gp120 and Depends on Modulation of the gp120-CCR5 InteractionJournal of Virology, 2002
- Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compoundsAntimicrobial Agents and Chemotherapy, 1994